Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.675    0.00 (0.00%)
Bid:
0.65
Ask:
0.70
Spread: 0.05 (7.692%)
Market Cap: £3.03m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

UK Government NPSA testing update

10 Jul 2026 07:00

RNS Number : 7890L
Thruvision Group PLC
10 July 2026
 

Reach - non-regulatory announcement

 

10 July 2026

Thruvision Group plc

UK Government National Protective Security Authority ("NPSA") testing update

 

Thruvision Group plc (AIM: THRU), a leading provider of walk-through security technology ("Thruvision" or the "Company" and, together with its subsidiary undertakings, the "Group"), today announces that the Thruvision 8108 WalkTHRU screening solution, including SmartSCREEN and DynamicDETECT with DDAlert, has been tested following the NPSA's Discriminative Threat Detection Systems Test Method. The testing is not pass/fail but shows that the system has capability for screening non-divested individuals for mass casualty threats.

 

The NPSA has confidence that Thruvision has followed the NPSA's Discriminative Threat Detection Systems Test Method in the testing of the Thruvision 8108 WalkTHRU solution and the results presented are an accurate reflection of system performance. The test method is not pass/fail and the NPSA does not endorse or approve specific products tested against it.

 

Notes for readers:

· The NPSA is the UK Government's National Technical Authority for physical and personnel security.

· As part of the Security Service, MI5, the NPSA makes the UK more resilient to terrorism and state threats.

· The results are available to security professionals and buyers interested in detecting both metallic and non-metallic threats to help them understand detection performance and throughput to align with their requirements to secure their facility from current and emerging threats.

· The 8108 WalkTHRU solution is Thruvision's standard product for high footfall deployments, including retail distribution centres, high profile sporting events and aviation worker screening, where peak flow rates can range up to 1,800 people per hour.

· The LPCDD7116, the previous generation solution, was previously tested in 2025.

 

For further information please contact:

 

Thruvision Group plc

Tom Black, Executive Chairman

Victoria Balchin, Chief Executive Officer and Chief Financial Officer

+44 (0)1235 425400

Allenby Capital Limited (Nominated Adviser and Broker)

James Reeve

Jos Pinnington / Amrit Nahal (Sales)

+44 (0)20 3328 5656

 

About Thruvision (www.thruvision.com)

Thruvision is a leading developer, manufacturer and supplier of walk-through security technology. Its technology is deployed in more than 30 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using an advanced AI-based detection algorithm. The Group has offices and manufacturing capability in the UK and US.

 

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSWFAUEMSEEW
Date   Source Headline
10th Jul 20267:00 amRNS-RUK Government NPSA testing update
26th Jun 20267:00 amRNSResults for the year ended 31 March 2026
23rd Jun 202610:58 amRNSNotice of Results
19th Jun 20267:00 amRNS-RRetail Distribution orders received Sensormatic
14th May 20267:00 amRNS-RNew Strategic Partnerships
7th May 202611:45 amRNSBlocklisting cancellation and interim review
7th May 202611:45 amRNSBlocklisting cancellation and interim review
8th Apr 20267:00 amRNSFY26 Trading Update
13th Mar 20267:00 amRNSUS Aviation Contract Award
13th Mar 20267:00 amRNSUS Aviation Contract Award
19th Feb 20267:00 amRNSHolding(s) in Company
19th Feb 20267:00 amRNSContract awards into UK custodial facilities
12th Feb 20267:00 amRNS-RFirst UK “Screening as a Service” Sales
22nd Jan 20267:00 amRNS-RUK Retail Distribution Contract Award
20th Jan 20267:00 amRNSSouth-East Asian Mass Transit Contract Award
12th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 202611:27 amRNSAward of Share Options
19th Dec 20251:07 pmRNS-RUS Retail Distribution Contract Award
19th Dec 20251:07 pmRNS-RUS Retail Distribution Contract Award
16th Dec 20257:00 amRNSHolding(s) in Company
11th Dec 20257:00 amRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RImminent contract award
4th Dec 20257:00 amRNSHolding(s) in Company
28th Nov 20253:45 pmRNSHolding(s) in Company
26th Nov 20257:00 amRNSHolding(s) in Company
25th Nov 20257:00 amRNSInterim Results and Trading Update
6th Nov 20254:30 pmRNSBlock listing Interim Review
6th Nov 20254:30 pmRNSBlock listing Interim Review
23rd Oct 202510:53 amRNSResult of AGM
23rd Oct 20257:00 amRNSAGM Statement and Trading Update
6th Oct 20251:49 pmRNS-RNPSA Testing Update
30th Sep 202512:33 pmRNSHolding(s) in Company
29th Sep 202512:04 pmRNSHolding(s) in Company
29th Sep 202511:26 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
19th Sep 20257:00 amRNSFinal Results
15th Sep 202512:40 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNS-RAdditions to Value-Added Reseller Network
1st Aug 20259:46 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSHolding(s) in Company
31st Jul 20255:00 pmRNSTotal Voting Rights
31st Jul 20252:37 pmRNSHolding(s) in Company
31st Jul 20252:01 pmRNSHolding(s) in Company
31st Jul 202510:32 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHolding(s) in Company
29th Jul 20251:54 pmRNSHolding(s) in Company
28th Jul 202510:50 amRNSResult of GM and completion of Capital Raising
28th Jul 20257:00 amRNSChange of Adviser
8th Jul 20257:00 amRNSResult of Retail Offer & Notice of General Meeting
4th Jul 20257:05 amRNSWRAP Retail Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.